4//SEC Filing
Smith Karen L. 4
Accession 0001209191-23-037192
CIK 0001827506other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:02 PM ET
Size
5.4 KB
Accession
0001209191-23-037192
Insider Transaction Report
Form 4
Smith Karen L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+20,500→ 20,500 totalExercise: $2.54Exp: 2033-06-13→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001639637
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:02 PM ET
- Size
- 5.4 KB